Quick Dispatch:
Your summit study tirzepatide Other clinical trials with tirzepatide 86-88 orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your summit study tirzepatide Other clinical trials with tirzepatide 86-88 ships.
Need Help?
Questions about summit study tirzepatide Other clinical trials with tirzepatide 86-88, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for summit study tirzepatide Other clinical trials with tirzepatide 86-88 in your area.
01200-X/asset/a888810c-3ccf-4f48-b252-0dfdf720d276/main.assets/gr3_lrg.jpg)
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
24.59
Tirzepatide: A Systematic Update
24.04
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
21.75
Frontiers
25.65
SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results
29.56
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis
24.28
💊 New research in obesity & heart failure The SUMMIT study looked at tirzepatide, a once-weekly injection, in people with both obesity and heart failure with preserved ejection fraction (HFpEF). Over 52
20.70
